Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829536 administering to a patient with lymphedema a therapeutically effective amount of a vascular endothelial growth factor D (VEGF-D) protein at the site of edema, that binds and stimulates wild-type VEGFR-3; genetic disorders; screening
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
11/09/2010US7829527 administering to a subject having cerebral vasospasm an effective amount for treating cerebral vasospasm of a R-type voltage-dependent calcium channel inhibitor SNX-482 ( a polypeptide from spider; toxin from the venom of the tarantula Hysterocrates gigas)
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829338 Dominant negative alleles of human mismatch repair genes introduced into cells and transgenic animals; prepared more efficiently than by relying on the natural rate of mutation
11/09/2010US7829336 Method for isolating a self-renewing, multipotent, slow-cycling cell
11/09/2010US7829330 Stresscopins and their uses
11/09/2010US7829329 Adenoviral vectors for treating disease
11/09/2010US7829322 Recombinant microorganism comprising inactivation of the AprX gene
11/09/2010US7829320 Asparaginases
11/09/2010US7829319 autoprotease Npro of Pestivirus, which have a lower pi and enhanced solubility are suitable for use in a wider range of conditions; production of heterologous polypeptides of interest with homogenous N-termini
11/09/2010US7829318 Transforming pichia with escherichia heat resistant acid phosphatase (APPA); monitor release of phosphorous from phytate
11/09/2010US7829316 using a bacterium which has been modified so as to increase the expression of a sucE1 gene or a product produced by any treatment of the bacterium with an organic raw material in a reaction solution containing a carbonate ion, a bicarbonate ion or carbon dioxide gas
11/09/2010US7829315 Production of peracids using an enzyme having perhydrolysis activity
11/09/2010US7829314 thermostable FEN-1 endonuclease and a polymerase; site-specific nuclease cleavage by a variety of enzymes
11/09/2010US7829311 Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
11/09/2010US7829310 Compositions of aminoacyl-tRNA synthetase and uses thereof
11/09/2010US7829308 Neurogenin
11/09/2010US7829307 Multimeric protein with linker having sequence ProValSerGlyProArg; [Gly2]hGLP-2 is produced from a multimeric precursor; genetic engineering and expression; biodrugs
11/09/2010US7829306 Protein highly producing recombinant animal cell, method for preparing the same, and method for mass-producing protein using the same
11/09/2010US7829293 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders
11/09/2010US7829290 Method and device for protein delivery into cells
11/09/2010US7829276 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829102 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s)
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010US7829089 Antibody to mammalian cytokine-like polypeptide-10
11/09/2010US7829083 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
11/09/2010US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject
11/09/2010US7829075 Method for expanding hematopoietic cells using cytokine zalpha11 ligand
11/09/2010CA2386242C Tumour-specific vector for gene therapy
11/09/2010CA2362794C Inhibitors of separase, method for identifying them and uses
11/09/2010CA2342305C Pestivirus mutants and vaccines containing the same
11/09/2010CA2319759C Transgenic crops accumulating fructose polymers and methods for their production
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/09/2010CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/09/2010CA2137815C Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
11/08/2010CA2665650A1 Primers and probes for detection of influenza type a viruses of subtype h1
11/07/2010CA2665735A1 Methods for producing plants with altered levels of sulphated secondary metabolites
11/04/2010WO2010127367A2 Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
11/04/2010WO2010127330A1 Dual-action inhibitors and methods of using same
11/04/2010WO2010127329A1 Dual-action inhibitors and methods of using same
11/04/2010WO2010127321A2 Biochemical platform for fuels and chemicals production from cellulosic biomass
11/04/2010WO2010127318A2 Product of fatty acid esters from biomass polymers
11/04/2010WO2010127304A2 Sequencing methods
11/04/2010WO2010127290A2 Improved isoprene hydrocarbon production using genetically engineered cyanobacteria
11/04/2010WO2010127252A2 Monoclonal antibodies to influenza h1n1 virus and uses thereof
11/04/2010WO2010127209A2 Compositions and methods for therapy of macular degeneration
11/04/2010WO2010127176A2 Methods and compositions for prognosing detecting age-related macular degeneration
11/04/2010WO2010127166A2 Combination anti-hiv vectors, targeting vectors, and methods of use
11/04/2010WO2010127115A1 Modified immunization vectors
11/04/2010WO2010127097A1 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
11/04/2010WO2010126772A1 Polypeptides having xylanase activity and polynucleotides encoding same
11/04/2010WO2010126375A1 A method for detection of human papillomavirus (hpv) type
11/04/2010WO2010126355A1 Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
11/04/2010WO2010126338A2 Biomarker for breast cancer diagnosis, and breast cancer diagnostics
11/04/2010WO2010126246A2 ANTI ErbB2 RNA APTAMER AND APPLICATIONS THEREFOR
11/04/2010WO2010126180A1 Creatine kinase fusion protein, preparation method thereof, and use thereof
11/04/2010WO2010126151A1 Novel malaria vaccine
11/04/2010WO2010126139A1 Protein-type electron mediator
11/04/2010WO2010126081A1 Method for solubilizing insoluble protein and/or peptide
11/04/2010WO2010126073A1 Expression cassette for secretion/expression of polypeptide, and use thereof
11/04/2010WO2010126066A1 Anti-il-3rα antibody for use in treatment of blood tumor
11/04/2010WO2010125872A1 Transgenic goldfish
11/04/2010WO2010125829A1 Process for production of 3-mercaptopropionic acid or salt thereof
11/04/2010WO2010125656A1 Disease-resistant transgenic bird capable of expressing foreign rna
11/04/2010WO2010125620A1 Method for inducing degradation of protein in mammalian cell
11/04/2010WO2010125588A1 Novel fusion tag offering solubility to insoluble recombinant protein
11/04/2010WO2010125312A1 Method for producing a protein of interest using a novel fusion protein
11/04/2010WO2010125296A1 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof
11/04/2010WO2010125293A1 Targeting nucleic acids in the mitochondria
11/04/2010WO2010125221A1 Genes homologous to the flowering locus t (ft) gene and the use thereof for modulating tuberization
11/04/2010WO2010125187A2 Method for the production of domain antibodies
11/04/2010WO2010125182A1 Concatamers for immunemodulation
11/04/2010WO2010125175A1 A fungal serine protease and use thereof
11/04/2010WO2010125174A1 A novel fungal protease and use thereof
11/04/2010WO2010125115A1 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
11/04/2010WO2010125036A2 Plants having enhanced yield-related traits and a method for making the same
11/04/2010WO2010124953A1 Plants having enhanced yield-related traits and a method for making the same
11/04/2010WO2010124874A1 Hepcidin binding nucleic acids
11/04/2010WO2010124530A1 Use of histone deacetylase gene oshdt1 in enhancing rice heterosis
11/04/2010WO2010124377A1 Mutants of francisella tularensis and uses thereof
11/04/2010WO2010124365A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010WO2010124361A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
11/04/2010WO2010124344A1 Plant nucleic acids associated with cellular ph and uses thereof
11/04/2010WO2010124324A1 Manipulating fructan biosynthesis and enhancing plant biomass
11/04/2010WO2010088395A3 Synthetic agonists of tlr 9
11/04/2010WO2010085373A3 Novel bacillus thuringiensis gene with lepidopteran activity
11/04/2010WO2010084331A3 Gene targeting in plants
11/04/2010WO2010081173A3 Modified antibody compositions, methods of making and using thereof
11/04/2010WO2010080570A3 Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
11/04/2010WO2010077288A3 Methods for identifying differences in alternative splicing between two rna samples
11/04/2010WO2010075188A3 Multibase delivery for long reads in sequencing by synthesis protocols
11/04/2010WO2010075101A3 Treating picornavirus infection by targeting microrna mir-141
11/04/2010WO2010071769A3 Chimeric l. monocytogens in1b protein
11/04/2010WO2010069542A8 Improved production of acid and solvent in microorganisms
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 4023